BioRestorative Therapies, Inc. Business Finance Contracts & Agreements
92 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (8)
- Loan Agreements (2)
- Note Agreements (23)
- Participation Agreements (5)
- Purchase Agreements (3)
- Security Agreements (2)
- Stock Agreements (26)
- Trust Agreements (1)
- Underwriting Agreements (5)
- Warrant Agreements (16)
- Non-Qualified Stock Option Award Agreement, dated as of February 13, 2024, between BioRestorative Therapies, Inc. and David Rosa (Filed With SEC on April 1, 2024)
- Non-Qualified Stock Option Award Agreement, dated as of February 13, 2024, between BioRestorative Therapies, Inc. and Patrick F. Williams (Filed With SEC on April 1, 2024)
- Non-Qualified Stock Option Award Agreement, dated as of February 13, 2024, between BioRestorative Therapies, Inc. and Nickolay Kukekov (Filed With SEC on April 1, 2024)
- COMMON STOCK PURCHASE WARRANT BIORESTORATIVE THERAPIES, INC. (Filed With SEC on February 8, 2024)
- COMMON STOCK PURCHASE WARRANT BIORESTORATIVE THERAPIES, INC. (Filed With SEC on February 8, 2024)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 13, 2023)
- Non-Qualified Stock Option Award Agreement, dated as of February 17, 2023, between BioRestorative Therapies, Inc. and David Rosa (Filed With SEC on March 27, 2023)
- Non-Qualified Stock Option Award Agreement, dated as of February 17, 2023, between BioRestorative Therapies, Inc. and Patrick F. Williams (Filed With SEC on March 27, 2023)
- Non-Qualified Stock Option Award Agreement, dated as of February 17, 2023, between BioRestorative Therapies, Inc. and Nickolay Kukekov (Filed With SEC on March 27, 2023)
- Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and David Rosa (Filed With SEC on March 30, 2022)
- Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Patrick F. Williams (Filed With SEC on March 30, 2022)
- Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Nickolay Kukekov (Filed With SEC on March 30, 2022)
- Amendment No. 2 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Francisco Silva (Filed With SEC on March 30, 2022)
- Amendment No. 2 to Non-Qualified Stock Option Award Agreement, dated as of December 10, 2021, between BioRestorative Therapies, Inc. and Lance Alstodt (Filed With SEC on March 30, 2022)
- Common Stock Purchase Warrant, dated November 9, 2021, issued by BioRestorative Therapies, Inc. to Auctus Fund, LLC (Filed With SEC on March 30, 2022)
- Common Stock Purchase Warrant, dated November 9, 2021, issued by BioRestorative Therapies, Inc. pursuant to public offering (Filed With SEC on March 30, 2022)
- Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Francisco Silva (Filed With SEC on March 30, 2022)
- Amendment No. 1 to Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Lance Alstodt (Filed With SEC on March 30, 2022)
- Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and David Rosa (Filed With SEC on March 30, 2022)
- Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Patrick F. Williams (Filed With SEC on March 30, 2022)
- Non-Qualified Stock Option Award Agreement, dated as of November 4, 2021, between BioRestorative Therapies, Inc. and Nickolay Kukekov (Filed With SEC on March 30, 2022)
- 2,300,000 SHARESOF COMMON STOCK AND 2,300,000 WARRANTS OF BIORESTORATIVE THERAPIES, INC. AMENDED AND RESTATED UNDERWRITING AGREEMENT (Filed With SEC on November 8, 2021)
- Form of Representative Warrant (Filed With SEC on November 4, 2021)
- Form of Investor Warrant (Filed With SEC on November 4, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 4, 2021)
- Exchange Agreement, dated as of October 22, 2021, between the Company and Crossover Capital Fund I, LLC (Filed With SEC on October 29, 2021)
- Form of Warrant Agency Agreement (Filed With SEC on October 29, 2021)
- Form of Investor Warrant (Filed With SEC on October 29, 2021)
- EXCHANGE AGREEMENT (Filed With SEC on October 20, 2021)
- EXCHANGE AGREEMENT (Filed With SEC on October 20, 2021)
- EXCHANGE AGREEMENT (Filed With SEC on October 20, 2021)
- Exchange Agreement, dated as of October 12, 2021, between BioRestorative Therapies, Inc. and Auctus Fund, LLC, including the form of Certificate of Designations of Series A... (Filed With SEC on October 18, 2021)
- 2010 Equity Participation Plan, as amended (Filed With SEC on March 18, 2021)
- SECURITY AGREEMENT (Filed With SEC on April 28, 2020)
- SECURED TERM NOTE (Filed With SEC on April 28, 2020)
- AMENDED AND RESTATED DIP LOAN AND SECURITY AGREEMENT by and between BIORESTORATIVE THERAPIES, INC., as Borrower and PHOENIX CELL GROUP HOLDINGS, LLC, as Lender Dated: March 30,... (Filed With SEC on April 3, 2020)
- AMENDED AND RESTATED STALKING HORSE ASSET PURCHASE AGREEMENT BY AND AMONG PHOENIX CELL GROUP HOLDINGS LLC, a Delaware limited liability company AND BIORESTORATIVE THERAPIES, INC.,... (Filed With SEC on April 3, 2020)
- DIP LOAN AND SECURITY AGREEMENT By and Between BIORESTORATICE THERAPIES, INC., as Borrower And PHOENIX CELL GROUP HOLDINGS, LLC, as Lender Dated: March 19, 2020 TABLE OF CONTENTS (Filed With SEC on March 20, 2020)
- STALKING HORSE ASSET PURCHASE AGREEMENT1 BY AND AMONG PHOENIX CELL GROUP HOLDINGS LLC, a Delaware limited liability company and BIORESTORATIVE THERAPIES, INC., a Delaware... (Filed With SEC on March 20, 2020)
- COMMON STOCK PURCHASE WARRANT BIORESTORATIVE THERAPIES, INC. (Filed With SEC on October 10, 2019)
